Sato K, Wu J, Kikuchi T, Wang Y, Watanabe I, Okumura F
Department of Anesthesiology, Yokohama City University School of Medicine, Japan.
Br J Anaesth. 1996 Sep;77(3):381-4. doi: 10.1093/bja/77.3.381.
Using microdialysis, we examined the effects of ketamine and pentobarbitone on acetylcholine (ACh) release from the rat hippocampus and striatum. Ketamine 25 and 50 mg kg-1 increased ACh release from the hippocampus to 295% and 353% of basal release, respectively, but not from the striatum. SCH 23390 1 mumol litre-1, a D1 antagonist, significantly inhibited the facilitatory effect of ketamine 50 mg kg-1 on hippocampal ACh release (to 241% of basal level). In contrast, pentobarbitone 20 and 40 mumg kg-1 decreased basal ACh release from both the hippocampus by 41% and 69%, respectively, and the striatum by 37% and 58%, respectively. The results suggest that ketamine and pentobarbitone exert opposite effects on ACh release from the rat hippocampus and that the stimulating effect of ketamine may involve dopamine D1 receptors.
我们采用微透析技术,研究了氯胺酮和戊巴比妥对大鼠海马体和纹状体乙酰胆碱(ACh)释放的影响。25毫克/千克和50毫克/千克的氯胺酮分别使海马体中的ACh释放量增加至基础释放量的295%和353%,但对纹状体中的ACh释放量没有影响。1微摩尔/升的D1拮抗剂SCH 23390显著抑制了50毫克/千克氯胺酮对海马体ACh释放的促进作用(降至基础水平的241%)。相比之下,20毫克/千克和40毫克/千克的戊巴比妥分别使海马体中的基础ACh释放量降低了41%和69%,使纹状体中的基础ACh释放量分别降低了37%和58%。结果表明,氯胺酮和戊巴比妥对大鼠海马体中ACh的释放具有相反的作用,且氯胺酮的刺激作用可能涉及多巴胺D1受体。